Matt Miksic

Stock Analyst at Barclays

(3.73)
# 768
Out of 4,984 analysts
295
Total ratings
59.66%
Success rate
4.22%
Average return

Stocks Rated by Matt Miksic

Senseonics Holdings
Aug 27, 2025
Initiates: Overweight
Price Target: $1.5
Current: $0.45
Upside: +235.20%
Humacyte
Aug 27, 2025
Initiates: Overweight
Price Target: $3.5
Current: $1.53
Upside: +128.76%
LivaNova
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $55$58
Current: $54.53
Upside: +6.36%
Insulet
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $266$300
Current: $322.22
Upside: -6.90%
Tandem Diabetes Care
Aug 8, 2025
Maintains: Overweight
Price Target: $53$51
Current: $12.18
Upside: +318.72%
Baxter International
Aug 4, 2025
Maintains: Overweight
Price Target: $41$36
Current: $23.20
Upside: +55.17%
Alphatec Holdings
Aug 4, 2025
Maintains: Overweight
Price Target: $21$22
Current: $14.70
Upside: +49.66%
InMode
Jul 30, 2025
Maintains: Overweight
Price Target: $24$21
Current: $14.93
Upside: +40.66%
DexCom
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $93$98
Current: $76.44
Upside: +28.21%
Edwards Lifesciences
Jul 25, 2025
Maintains: Overweight
Price Target: $90$95
Current: $75.20
Upside: +26.33%
Maintains: Overweight
Price Target: $125$133
Current: $98.50
Upside: +35.03%
Upgrades: Equal-Weight
Price Target: $9$19
Current: $18.88
Upside: +0.64%
Maintains: Equal-Weight
Price Target: $165$176
Current: $177.20
Upside: -0.68%
Maintains: Equal-Weight
Price Target: $19$16
Current: $15.12
Upside: +5.82%
Maintains: Overweight
Price Target: $261$241
Current: $187.57
Upside: +28.49%
Maintains: Overweight
Price Target: $16$12
Current: $2.46
Upside: +387.80%
Maintains: Overweight
Price Target: $684$635
Current: $433.66
Upside: +46.43%
Maintains: Overweight
Price Target: $158$159
Current: $134.17
Upside: +18.51%
Maintains: Overweight
Price Target: $100$103
Current: $56.22
Upside: +83.21%
Maintains: Underweight
Price Target: $118$112
Current: $99.92
Upside: +12.09%
Maintains: Overweight
Price Target: $418$443
Current: $376.88
Upside: +17.54%
Initiates: Overweight
Price Target: $22
Current: $5.61
Upside: +292.16%
Maintains: Overweight
Price Target: $105$109
Current: $94.58
Upside: +15.25%
Assumes: Outperform
Price Target: $96
Current: $77.20
Upside: +24.35%
Assumes: Outperform
Price Target: $100
Current: $67.37
Upside: +48.43%
Maintains: Outperform
Price Target: $722$418
Current: $129.44
Upside: +222.93%
Maintains: Outperform
Price Target: $31$28
Current: $16.25
Upside: +72.31%
Maintains: Outperform
Price Target: $68$67
Current: $13.43
Upside: +398.88%
Initiates: Outperform
Price Target: $480
Current: $6.18
Upside: +7,666.99%
Maintains: Outperform
Price Target: $84$87
Current: $14.80
Upside: +487.84%
Maintains: Outperform
Price Target: $24$25
Current: $4.62
Upside: +441.13%
Initiates: Sell
Price Target: $9
Current: $6.94
Upside: +29.68%